MicuRx Pharma Of China Allies With Shanghai JV Firm To Develop MRX-I
This article was originally published in PharmAsia News
Executive Summary
China's MicuRx Pharma has formed an alliance with a Shanghai venture capital company to develop MicuRx's MRX-I antibiotic oral drug for multi-drug resistant gram-positive bacteria.